Patient Stories: How Palliative Care Helps with Anxiety, Pain, and More

https://getpalliativecare.org/patient-stories-how-palliative-care-helps-with-anxiety-pain-and-more/?utm_source=Get+Palliative+Care&utm_campaign=8c570c48c4-GPC+-+Sheralin+Patient+Story+%2F+04.15.26&utm_medium=email&utm_term=0_4ef32a103e-8c570c48c4-378264050 Sometimes, reading about palliative care isn’t enough, hearing someone’s story brings its impact to life. Sheralin cares for her mother, who has young-onset Alzheimer’s disease. Once a strong, hardworking single mother, her mom’s diagnosis brought unexpected challenges. Palliative care offered the support she needed. The team helped coordinate additional care for her mother while also supporting Sheralin’s own stress, depression, and anxiety, giving her tools to navigate the emotional realities of caregiving.

Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates Authors: Bernadett Szabados, MD; Maria De Santis, MD; Neal D. Shore, MD, FACS

https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?page=1&src=mkmcmr_driv_stan_mscpedu_260415-OUS-HONC-immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af-cta&uac=148436CN

Targeting chromosomal chaos Accent Therapeutics advances a KIF18A inhibitor, leveraging genomic instability to create druggable dependencies.

https://www.drugdiscoverynews.com/targeting-chromosomal-chaos-17128 At the 2026 international conference of the Society for Laboratory Automation and Screening (SLAS), Serena Silver, Chief Scientific Officer of Accent Therapeutics, laid out a precision oncology strategy built around a structural feature of cancer genomes rather than a single mutated gene.

Bicillin® L-A Shortage

https://www.hiv.gov/blog/bicillin-l-a-shortage?utm_source=newsletter&utm_medium=email&utm_campaign=blog&j=2951969&sfmc_sub=6992026&l=6498_HTML&u=73303456&mid=100006181&jb=0 CDC has learned that the U.S. Food and Drug Administration (FDA) is allowing the temporary importation of Lentocilin© due to the ongoing limited availability and extended recovery of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension, produced by King Pharmaceuticals LLC, a subsidiary of Pfizer). The National Network of STD Prevention Training Centers has posted information for health care providers on the administration of Lentocilin©. https://courses.nnptc.org/resource_detail.html?id=2718

Keys to Diagnosing 'Broken Heart Syndrome' (Takotsubo Cardiomyopathy) Mark P. Brady, PA-C; Yasmine S. Ali, MD, MSci, FACC, FACCP April 09, 2026

https://reference.medscape.com/p11/keys-diagnosing-broken-heart-syndrome-takotsubo-2026a10009hh?ecd=mkm_ret_260416_mscpmrk-OUS_DisReferences_etid8256303&uac=148436CN&impID=8256303 Takotsubo Cardiomyopathy (TCM) TCM, first described in 1990 by Sato et al,[1,2,3] is a transient cardiac syndrome that typically involves left ventricular (LV) apical akinesis and basal hypercontraction; it may symptomatically mimic acute coronary syndrome (ACS).[1,2,4]

Putting placebo effects in a new light The Lancet Psychiatry ++... + +

Putting placebo effects in a new light The Lancet Psychiatry https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00096-9/fulltext?dgcid=raven_jbs_etoc_email May 2026 Volume 13Number 5p365-444, e8 https://www.thelancet.com/journals/lanpsy/issue/vol13no5/PIIS2215-0366(26)X2003-X Harnessing placebo effects and mitigating nocebo effects: implications for clinical practice in psychiatry and medicine Matthew J Burke, MDa,b,c,d matt.burke@utoronto.ca ∙ Dasha A Sandra, MSce ∙ Marta Peciña, MDg ∙ Jay A Olson, PhDf ∙ Adriano Mollica, MDa,c ∙ Matthew Butler, MDh ∙ et al. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00340-2/abstract?dgcid=raven_jbs_etoc_feature_lanpsy Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST–MST): a randomised, double-blind, non-inferiority trial in Canada and the USA Prof Daniel M Blumberger, MDa,b daniel.blumberger@camh.ca ∙ Prof Shawn M McClintock, PhDe,f ∙ Kevin E Thorpe, MMathc,g ∙ Prof Carol A Tamminga, MDe ∙ Karen Foleyd,h ∙ Prof Mustafa M Husain, MDe ∙ et al. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00060-X/fulltext?dgcid=raven_jbs_etoc_feature_lanpsy

Autism spectrum disorder: strengthening screening for optimal outcomes The Lancet Regional Health – Southeast Asia + + +...

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial Praveen Kumar Marimuthua Drmpk91@gmail.com ∙ Chitra Renukaradhyab chitraardhya@gmail.com ∙ Shalini Sahuc sahushalini07@gmail.com ∙ Ajoy Oommen Johna ajoyoommenjohn@gmail.com ∙ Amit Jiwan Tirkeyd jiwan@cmcvellore.ac.in ∙ Balu Krishna Sasidharane balunair@cmcvellore.ac.in ∙ et al. https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(26)00028-4/fulltext?dgcid=raven_jbs_etoc_feature_lansea Autism spectrum disorder: strengthening screening for optimal outcomes The Lancet Regional Health – Southeast Asia https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(26)00056-9/fulltext?dgcid=raven_jbs_etoc_email Apr 2026 Volume 47 https://www.thelancet.com/journals/lansea/issue/vol47nonull/PIIS2772-3682(26)X2002-9